By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TONIX Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
TONIX Pharmaceuticals, Inc. (TNXP) Presents On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2015 Military Health System Research Symposium 8/19/2015 7:47:33 AM
TONIX Pharmaceuticals, Inc. (TNXP) Closes $20.1 Million Public Offering Of Common Stock 7/17/2015 11:11:52 AM
TONIX Pharmaceuticals, Inc. (TNXP) Announces Proposed Public Offering Of Common Stock 7/14/2015 7:34:20 AM
TONIX Pharmaceuticals, Inc. (TNXP) Prices Underwritten Public Offering Of Common Stock 7/14/2015 7:32:35 AM
TONIX Pharmaceuticals, Inc. (TNXP) Presents Non-Clinical Data On TNX-201 At The 57th Annual Scientific Meeting Of The American Headache Society 6/23/2015 6:29:52 AM
TONIX Pharmaceuticals, Inc. (TNXP) Announces Conditional Acceptance Of Tonmya As Proposed Brand Name For Cyclobenzaprine Hcl Sublingual Tablets, 2.8 Mg 6/17/2015 8:03:29 AM
TONIX Pharmaceuticals, Inc. (TNXP) Initiates Phase II Clinical Study Of TNX-201 In Episodic Tension-Type Headache 6/16/2015 7:57:41 AM
TONIX Pharmaceuticals, Inc. (TNXP) Presents Additional Data From Phase IIb BESTFIT Clinical Study At EULAR 6/11/2015 7:38:25 AM
TONIX Pharmaceuticals, Inc. (TNXP) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/28/2015 6:57:59 AM
TONIX Pharmaceuticals, Inc. (TNXP) Announces Acceptance Of Two Abstracts For Presentation At EULAR 5/27/2015 7:57:50 AM
123456789
//-->